RIGEL PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-06.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2012-03-06
- RIGEL PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $0.00.
- RIGEL PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
- RIGEL PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2009 was $616.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-03-06 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-06 |
| 2009-12-31 | $616.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |